Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
10896 | 1027 | 36.1 | 78% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
275 | 3 | NSAIDS//CYCLOOXYGENASE//CYCLOOXYGENASE 2 | 43399 |
1311 | 2 | PROSTAGLANDIN D 2//CRTH2//MOL BEHAV BIOL | 8520 |
10896 | 1 | CRTH2//PROSTAGLANDIN D 2//MOL BEHAV BIOL | 1027 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CRTH2 | authKW | 1756114 | 8% | 76% | 78 |
2 | PROSTAGLANDIN D 2 | authKW | 1709080 | 14% | 39% | 148 |
3 | MOL BEHAV BIOL | address | 1560164 | 11% | 46% | 115 |
4 | PROSTAGLANDIN D SYNTHASE | authKW | 656451 | 4% | 60% | 37 |
5 | PGD2 | authKW | 635221 | 5% | 43% | 50 |
6 | DP RECEPTOR | authKW | 611603 | 2% | 86% | 24 |
7 | LIPOCALIN TYPE PROSTAGLANDIN D SYNTHASE | authKW | 502197 | 2% | 68% | 25 |
8 | BETA TRACE | authKW | 412794 | 2% | 73% | 19 |
9 | CRTH2 ANTAGONIST | authKW | 390550 | 2% | 77% | 17 |
10 | DP2 | authKW | 295555 | 1% | 76% | 13 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Allergy | 1409 | 6% | 0% | 58 |
2 | Biochemistry & Molecular Biology | 1037 | 29% | 0% | 299 |
3 | Chemistry, Medicinal | 1013 | 10% | 0% | 102 |
4 | Pharmacology & Pharmacy | 831 | 19% | 0% | 191 |
5 | Immunology | 609 | 13% | 0% | 136 |
6 | Neurosciences | 316 | 13% | 0% | 129 |
7 | Cell Biology | 233 | 10% | 0% | 99 |
8 | Endocrinology & Metabolism | 173 | 6% | 0% | 64 |
9 | Biophysics | 156 | 6% | 0% | 57 |
10 | Respiratory System | 146 | 4% | 0% | 38 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOL BEHAV BIOL | 1560164 | 11% | 46% | 115 |
2 | HUMAN GENE SCI | 141042 | 2% | 22% | 22 |
3 | ADV MED DEV | 122306 | 1% | 34% | 12 |
4 | OSAKA BIOSCI | 85687 | 1% | 41% | 7 |
5 | ANIM RADIOL | 59454 | 1% | 33% | 6 |
6 | MENTAL HLTH ENVIRONM EFFECTS | 47565 | 0% | 40% | 4 |
7 | ABENO KU MED | 29731 | 0% | 100% | 1 |
8 | ANTIBACT IMMUNOL CANC | 29731 | 0% | 100% | 1 |
9 | BIOL BEHAV MOL | 29731 | 0% | 100% | 1 |
10 | BIOQUIM CLININFIBIOC PROT | 29731 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PROSTAGLANDINS & OTHER LIPID MEDIATORS | 13811 | 3% | 2% | 29 |
2 | ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH | 4521 | 1% | 1% | 11 |
3 | PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 3783 | 2% | 1% | 20 |
4 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2123 | 4% | 0% | 43 |
5 | JOURNAL OF LIPID MEDIATORS | 1735 | 0% | 1% | 4 |
6 | PROSTAGLANDINS | 1623 | 1% | 1% | 9 |
7 | EXPERT OPINION ON THERAPEUTIC PATENTS | 1066 | 1% | 0% | 9 |
8 | JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 984 | 2% | 0% | 19 |
9 | JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING | 960 | 0% | 1% | 3 |
10 | BRITISH JOURNAL OF PHARMACOLOGY | 776 | 2% | 0% | 22 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CRTH2 | 1756114 | 8% | 76% | 78 | Search CRTH2 | Search CRTH2 |
2 | PROSTAGLANDIN D 2 | 1709080 | 14% | 39% | 148 | Search PROSTAGLANDIN+D+2 | Search PROSTAGLANDIN+D+2 |
3 | PROSTAGLANDIN D SYNTHASE | 656451 | 4% | 60% | 37 | Search PROSTAGLANDIN+D+SYNTHASE | Search PROSTAGLANDIN+D+SYNTHASE |
4 | PGD2 | 635221 | 5% | 43% | 50 | Search PGD2 | Search PGD2 |
5 | DP RECEPTOR | 611603 | 2% | 86% | 24 | Search DP+RECEPTOR | Search DP+RECEPTOR |
6 | LIPOCALIN TYPE PROSTAGLANDIN D SYNTHASE | 502197 | 2% | 68% | 25 | Search LIPOCALIN+TYPE+PROSTAGLANDIN+D+SYNTHASE | Search LIPOCALIN+TYPE+PROSTAGLANDIN+D+SYNTHASE |
7 | BETA TRACE | 412794 | 2% | 73% | 19 | Search BETA+TRACE | Search BETA+TRACE |
8 | CRTH2 ANTAGONIST | 390550 | 2% | 77% | 17 | Search CRTH2+ANTAGONIST | Search CRTH2+ANTAGONIST |
9 | DP2 | 295555 | 1% | 76% | 13 | Search DP2 | Search DP2 |
10 | L PGDS | 228378 | 1% | 59% | 13 | Search L+PGDS | Search L+PGDS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SCHULIGOI, R , STURM, E , LUSCHNIG, P , KONYA, V , PHILIPOSE, S , SEDEJ, M , WALDHOER, M , PESKAR, BA , HEINEMANN, A , (2010) CRTH2 AND D-TYPE PROSTANOID RECEPTOR ANTAGONISTS AS NOVEL THERAPEUTIC AGENTS FOR INFLAMMATORY DISEASES.PHARMACOLOGY. VOL. 85. ISSUE 6. P. 372-382 | 88 | 63% | 53 |
2 | SANTINI, G , MORES, N , MALERBA, M , MONDINO, C , MACIS, G , MONTUSCHI, P , (2016) INVESTIGATIONAL PROSTAGLANDIN D-2 RECEPTOR ANTAGONISTS FOR AIRWAY INFLAMMATION.EXPERT OPINION ON INVESTIGATIONAL DRUGS. VOL. 25. ISSUE 6. P. 639 -652 | 55 | 79% | 2 |
3 | ULVEN, T , KOSTENIS, E , (2010) NOVEL CRTH2 ANTAGONISTS: A REVIEW OF PATENTS FROM 2006 TO 2009.EXPERT OPINION ON THERAPEUTIC PATENTS. VOL. 20. ISSUE 11. P. 1505-1530 | 53 | 93% | 34 |
4 | PETTIPHER, R , HANSEL, TT , ARMER, R , (2007) ANTAGONISM OF THE PROSTAGLANDIN D-2 RECEPTORS DP1 AND CRTH2 AS AN APPROACH TO TREAT ALLERGIC DISEASES.NATURE REVIEWS DRUG DISCOVERY. VOL. 6. ISSUE 4. P. 313 -325 | 65 | 65% | 149 |
5 | PETTIPHER, R , WHITTAKER, M , (2012) UPDATE ON THE DEVELOPMENT OF ANTAGONISTS OF CHEMOATTRACTANT RECEPTOR-HOMOLOGOUS MOLECULE EXPRESSED ON TH2 CELLS (CRTH2). FROM LEAD OPTIMIZATION TO CLINICAL PROOF-OF-CONCEPT IN ASTHMA AND ALLERGIC RHINITIS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 55. ISSUE 7. P. 2915-2931 | 54 | 76% | 38 |
6 | URADE, Y , HAYAISHI, O , (2000) BIOCHEMICAL, STRUCTURAL, GENETIC, PHYSIOLOGICAL, AND PATHOPHYSIOLOGICAL FEATURES OF LIPOCALIN-TYPE PROSTAGLANDIN D SYNTHASE.BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY. VOL. 1482. ISSUE 1-2. P. 259 -271 | 70 | 74% | 200 |
7 | ULVEN, T , KOSTENIS, E , (2006) TARGETING THE PROSTAGLANDIN D-2 RECEPTORS DP AND CRTH2 FOR TREATMENT OF INFLAMMATION.CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 6. ISSUE 13. P. 1427 -1444 | 69 | 77% | 26 |
8 | URADE, Y , HAYAISHI, O , (2000) PROSTAGLANDIN D SYNTHASE: STRUCTURE AND FUNCTION.VITAMINS AND HORMONES - ADVANCES IN RESEARCH AND APPLICATIONS, VOL 58. VOL. 58. ISSUE . P. 89 -120 | 90 | 58% | 167 |
9 | PETTIPHER, R , (2008) THE ROLES OF THE PROSTAGLANDIN D-2 RECEPTORS DP1 AND CRTH2 IN PROMOTING ALLERGIC RESPONSES.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 153. ISSUE . P. S191 -S199 | 56 | 62% | 81 |
10 | CROSIGNANI, S , PRETRE, A , JORAND-LEBRUN, C , FRABOULET, G , SEENISAMY, J , AUGUSTINE, JK , MISSOTTEN, M , HUMBERT, Y , CLEVA, C , ABLA, N , ET AL (2011) DISCOVERY OF POTENT, SELECTIVE, AND ORALLY BIOAVAILABLE ALKYNYLPHENOXYACETIC ACID CRTH2 (DP2) RECEPTOR ANTAGONISTS FOR THE TREATMENT OF ALLERGIC INFLAMMATORY DISEASES.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 54. ISSUE 20. P. 7299 -7317 | 40 | 89% | 16 |
Classes with closest relation at Level 1 |